20/20 BioLabs meets with East Asia partners to explore expansion Jul 27, 2026 04:30PM
20/20 BioLabs reaches standstill deal on Series E preferred stock Jul 23, 2026 08:32AM
20/20 BioLabs reports Q2 revenue growth, outlines Medicare strategy Jul 9, 2026 04:01PM
20/20 Biolabs prepares contingency plans for Ebola and Hantavirus testing May 22, 2026 08:31AM
Maxim Group Starts 20/20 Biolabs (AIDX) at Buy May 11, 2026 07:40AM


Apr 10, 2026 10:00AM BIO-key International, 20/20 Biolabs, Society Pass, and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Feb 19, 2026 09:03AM 20/20 BioLabs begins trading on NASDAQ under ticker AIDX